Physician profile
David Wayne Riem
NPI 1255829453
$1,056.94
in general payments reported to CMS, 2019-2025
13 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.89 · 2022: $231 · 2023: $194 · 2024: $291 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.02 | 2022-2025 | |
| Pfizer INC. | $141.88 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $134.85 | 2022-2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $122.95 | 2022-2025 | Ultomiris |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.40 | 2021-2025 | Xifaxan |
| Mallinckrodt Hospital Products INC. | $91.33 | 2022-2025 | Terlivaz |
| Smith+Nephew, INC. | $64.18 | 2023-2025 | Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $59.32 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021-2023 | Gattex |
| E.R. Squibb & Sons, L.L.C. | $51.42 | 2022-2023 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $33.02 | 2022 | |
| Gilead Sciences, INC. | $14.96 | 2021 | |
| Scpharmaceuticals INC. | $13.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Riem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.